| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $41.5B | $43.5B | $46.3B | $51.8B | $47.3B | $42.9B | $15.4B | $13.5B |
| Cost of Revenue | $32.1B | $33.8B | $36.4B | $40.1B | $36.7B | $32.9B | — | — |
| Gross Profit | $9.4B | $9.6B | $9.9B | $11.6B | $10.6B | $3.3B | $3.4B | $3.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $7.7B | $7.9B | $8.0B | $8.6B | $7.9B | $8.0B | $8.0B | $7.5B |
| Operating Income | $1.3B | $1.6B | $1.8B | $3.0B | $2.4B | $1.0B | $0.9B | $0.9B |
| Net Income | $0.9B | $1.2B | $1.4B | $2.5B | $1.8B | $0.7B | $0.4B | $0.6B |
| EPS (Basic) | $4.31 | $5.70 | $6.31 | $9.94 | $6.93 | $5.30 | $3.33 | $3.86 |
| EPS (Diluted) | $4.28 | $5.68 | $6.29 | $9.84 | $6.84 | $2.69 | $1.23 | $1.91 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.8B | $15.0B | $15.8B | $17.5B | $19.1B | $12.9B | $13.0B | $13.9B |
| Current Assets | $8.2B | $7.9B | $8.8B | $10.5B | $12.5B | $8.9B | $9.8B | $10.5B |
| Cash & Equivalents | $1.6B | $1.4B | $1.9B | $2.9B | $5.5B | $2.0B | $1.1B | $2.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $8.0B | $7.9B | $9.0B | $10.7B | $10.5B | $7.5B | $7.8B | $7.1B |
| Stockholders' Equity | $2.8B | $3.1B | $2.8B | $3.0B | $4.6B | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.1B | $1.5B | $1.8B | $3.3B | $4.9B | $2.4B | $2.1B | $2.5B |
| Investing Cash Flow | $-0.7B | $-0.8B | $-1.0B | $-1.4B | $-0.8B | $0.5B | $-1.0B | $-0.9B |
| Capital Expenditures | $0.7B | $0.8B | $0.9B | $0.7B | $0.7B | $0.8B | $0.7B | $0.6B |
| Financing Cash Flow | $-1.3B | $-1.1B | $-1.8B | $-4.3B | $-0.9B | $-2.0B | $-2.3B | $-1.4B |